Reports of esophageal cancer with oral bisphosphonate use

N Engl J Med. 2009 Jan 1;360(1):89-90. doi: 10.1056/NEJMc0808738.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Oral
  • Aged
  • Alendronate / adverse effects*
  • Bone Density Conservation Agents / adverse effects*
  • Diphosphonates / adverse effects
  • Esophageal Neoplasms / chemically induced*
  • Esophageal Neoplasms / epidemiology
  • Esophageal Neoplasms / mortality
  • Europe / epidemiology
  • Female
  • Humans
  • Japan / epidemiology
  • Male
  • Risk Factors
  • United States / epidemiology

Substances

  • Bone Density Conservation Agents
  • Diphosphonates
  • Alendronate